{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:59:03Z","timestamp":1791896343197,"version":"4.3.4"},"reference-count":13,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["Division of Internal Medicine Developmental Funds"],"award-info":[{"award-number":["Division of Internal Medicine Developmental Funds"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2021,5,28]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>With durable cancer responses, genetically modified cell therapies are being implemented in various cancers. However, these immune effector cell therapies can cause toxicities, including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Pseudogout arthritis is an inflammatory arthritis induced by deposition of calcium pyrophosphate dihydrate crystals. Here, we report a case of pseudogout arthritis in a patient treated with MAGE-A4 directed T cell receptor T cells, for fallopian tube cancer. The patient developed CRS and ICANS 7\u2009days after infusion of the T cells. Concurrently, the patient newly developed sudden onset of left knee arthritis. Synovial fluid analyses revealed the presence of calcium pyrophosphate dihydrate crystal. Notably, the pseudogout arthritis was resolved with tocilizumab, which was administered for the treatment of CRS and ICANS. Immunoprofiling of the synovial fluid showed that the proportion of inflammatory interleukin 17 (IL-17)-producing CD4<jats:sup>+<\/jats:sup> T (Th17) cells and amount of IL-6 were notably increased, suggesting a potential role of Th17 cells in pseudogout arthritis after T-cell therapy. To the best of our knowledge, this is the first reported case of pseudogout arthritis after cell therapy. Clinicians, especially hematologists, oncologists and rheumatologists, should be aware that pseudogout arthritis can be associated with CRS\/ICANS.<\/jats:p>","DOI":"10.1136\/jitc-2021-002716","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:05:52Z","timestamp":1625663152000},"page":"e002716","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab"],"prefix":"10.1136","volume":"9","author":[{"given":"Sang T.","family":"Kim","sequence":"first","affiliation":[{"name":"General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Tayar","sequence":"additional","affiliation":[{"name":"General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqing","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danxia","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Norry","sequence":"additional","affiliation":[{"name":"Adaptimmune Therapeutics plc, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Sun","sequence":"additional","affiliation":[{"name":"Adaptimmune Therapeutics plc, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli","family":"Miller","sequence":"additional","affiliation":[{"name":"Adaptimmune Therapeutics plc, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"2025100312174452000_9.7.e002716.1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001511"},{"key":"2025100312174452000_9.7.e002716.2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","article-title":"Recent advances in car T-cell toxicity: mechanisms, manifestations and management","volume":"34","author":"Brudno","year":"2019","journal-title":"Blood Rev"},{"key":"2025100312174452000_9.7.e002716.3","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-018-0324-z"},{"key":"2025100312174452000_9.7.e002716.4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hon.2595","article-title":"Managing the toxicities of car T-cell therapy","volume":"37 Suppl 1","author":"Neelapu","year":"2019","journal-title":"Hematol Oncol"},{"key":"2025100312174452000_9.7.e002716.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2009.00860.x"},{"key":"2025100312174452000_9.7.e002716.6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep081"},{"key":"2025100312174452000_9.7.e002716.7","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0597-x"},{"key":"2025100312174452000_9.7.e002716.8","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.58"},{"key":"2025100312174452000_9.7.e002716.9","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw2262","article-title":"T\n                  H\n               17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity","volume":"5","author":"Harbour","year":"2020","journal-title":"Sci Immunol"},{"key":"2025100312174452000_9.7.e002716.10","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020008865","article-title":"Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma","author":"Strati","year":"2021","journal-title":"Blood"},{"key":"2025100312174452000_9.7.e002716.11","doi-asserted-by":"publisher","DOI":"10.1038\/nature06939"},{"key":"2025100312174452000_9.7.e002716.12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/EDBK_238691","article-title":"The other side of car T-cell therapy: cytokine release syndrome, neurologic toxicity, and financial burden","volume":"39","author":"Santomasso","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2025100312174452000_9.7.e002716.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.10.002"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2021-002716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:17:51Z","timestamp":1759519071000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2021-002716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":13,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,7]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/jitc-2021-002716"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2021-002716","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}